AADI: Aadi Bioscience, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 69.75
Enterprise Value ($M) 39.22
Book Value ($M) 68.87
Book Value / Share 2.79
Price / Book 1.01
NCAV ($M) 60.48
NCAV / Share 2.45
Price / NCAV 1.15

Profitability (mra)
Return on Invested Capital (ROIC) -0.88
Return on Assets (ROA) -0.47
Return on Equity (ROE) -0.59

Liquidity (mrq)
Quick Ratio 4.54
Current Ratio 4.89

Balance Sheet (mrq) ($M)
Current Assets 77.31
Assets 85.70
Liabilities 16.83
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
5 days ago 13D/A BML Investment Partners, L.P.
01-29 13G Point72 Asset Management, L.P.
01-24 13D/A Acuta Capital Partners, Llc
12-23 13D/A Desai Neil
12-23 13D/A Avoro Capital Advisors LLC
09-03 13G EcoR1 Capital, LLC 7.50

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-07 20,485 66,109 30.99
2025-02-06 6,405 48,952 13.08
2025-02-05 18,577 47,360 39.23
2025-02-04 16,637 85,223 19.52
2025-02-03 90,640 152,898 59.28

(click for more detail)

Similar Companies
ABEO – Abeona Therapeutics Inc. ABVC – ABVC BioPharma, Inc.


Financial data and stock pages provided by
Fintel.io